RSCM
ALXN

Rock Springs Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-306,750
Closed -$47.9M 168
2020
Q4
$47.9M Buy
306,750
+81,750
+36% +$12.8M 1.02% 30
2020
Q3
$25.7M Buy
225,000
+41,500
+23% +$4.75M 0.65% 49
2020
Q2
$20.6M Buy
+183,500
New +$20.6M 0.56% 59
2019
Q3
Sell
-242,500
Closed -$31.8M 144
2019
Q2
$31.8M Hold
242,500
1.15% 25
2019
Q1
$32.8M Hold
242,500
1.26% 21
2018
Q4
$23.6M Sell
242,500
-57,500
-19% -$5.6M 1.11% 26
2018
Q3
$41.7M Sell
300,000
-192,500
-39% -$26.8M 1.51% 14
2018
Q2
$61.1M Buy
492,500
+7,500
+2% +$931K 2.35% 6
2018
Q1
$54.1M Buy
485,000
+5,000
+1% +$557K 2.31% 4
2017
Q4
$57.4M Buy
480,000
+17,000
+4% +$2.03M 2.6% 4
2017
Q3
$65M Hold
463,000
3% 2
2017
Q2
$56.3M Buy
463,000
+6,100
+1% +$742K 2.84% 5
2017
Q1
$55.4M Sell
456,900
-8,100
-2% -$982K 3.2% 3
2016
Q4
$56.9M Buy
465,000
+197,750
+74% +$24.2M 3.81% 2
2016
Q3
$32.7M Buy
267,250
+31,750
+13% +$3.89M 2.05% 11
2016
Q2
$27.5M Buy
235,500
+7,750
+3% +$905K 2.04% 12
2016
Q1
$31.7M Buy
227,750
+34,750
+18% +$4.84M 2.66% 6
2015
Q4
$36.8M Buy
193,000
+21,000
+12% +$4.01M 2.79% 4
2015
Q3
$26.9M Buy
172,000
+17,500
+11% +$2.74M 2.18% 8
2015
Q2
$27.9M Buy
154,500
+46,250
+43% +$8.36M 2.04% 11
2015
Q1
$18.8M Buy
108,250
+15,750
+17% +$2.73M 1.75% 16
2014
Q4
$17.1M Buy
92,500
+2,750
+3% +$509K 2% 15
2014
Q3
$14.9M Buy
89,750
+4,000
+5% +$663K 2.3% 11
2014
Q2
$13.4M Buy
85,750
+37,250
+77% +$5.82M 2.4% 12
2014
Q1
$7.38M Sell
48,500
-2,500
-5% -$380K 1.7% 21
2013
Q4
$6.79M Buy
+51,000
New +$6.79M 2.42% 14